Tom Bumol, Ph.D. , vice president of biotechnology discovery research at Eli Lilly and Company, is heading up Lilly's new biotechnology center in San Diego, which is focused on discovering and engineering potential biologic medicines, with an emphasis on cancer, diabetes and autoimmune diseases.